We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
Cap. Flow
+$723M
Cap. Flow %
2.6%
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175

Sector Composition

Rank Sector Weight
1 Financials 4.74%
2 Technology 4.11%
3 Healthcare 2.19%
4 Energy 2.03%
5 Consumer Discretionary 1.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPRT
1826
Westport Fuel Systems
WPRT
$36.5M
$19K ﹤0.01%
1,253
+46
+4% +$674
JPM icon
1827
PUT
JPMorgan Chase
JPM
$939B
$18K ﹤0.01%
2,000
LTBR icon
1828
Lightbridge
LTBR
$246M
$18K ﹤0.01%
2,692
QUIK icon
1829
QuickLogic
QUIK
$224M
$18K ﹤0.01%
2,091
ASM
1830
Avino Silver & Gold Mines
ASM
$987M
$17K ﹤0.01%
27,500
-1,000
-4% -$639
STZ icon
1831
CALL
Constellation Brands
STZ
$22.2B
$17K ﹤0.01%
4,200
+500
+14% +$84.2K
SPGI icon
1832
PUT
S&P Global
SPGI
$126B
$16K ﹤0.01%
3,000
TGB
1833
Trekor Metals
TGB
$2.56B
$16K ﹤0.01%
27,900
+6,000
+27% +$3.58K
VERU icon
1834
Veru
VERU
$36.1M
$16K ﹤0.01%
1,102
GSV
1835
DELISTED
Gold Standard Ventures Corp.
GSV
$16K ﹤0.01%
15,232
+1,400
+10% +$1.67K
NAVB
1836
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$16K ﹤0.01%
5,805
GS icon
1837
CALL
Goldman Sachs
GS
$313B
$15K ﹤0.01%
600
AGRX
1838
DELISTED
Agile Therapeutics
AGRX
$15K ﹤0.01%
5
AMPE
1839
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$15K ﹤0.01%
88
GNCA
1840
DELISTED
Genocea Biosciences, Inc.
GNCA
$15K ﹤0.01%
3,138
CARM
1841
DELISTED
Carisma Therapeutics
CARM
$14K ﹤0.01%
660
LGMK
1842
DELISTED
LogicMark
LGMK
$14K ﹤0.01%
3
MA icon
1843
PUT
Mastercard
MA
$477B
$14K ﹤0.01%
2,000
URG
1844
Ur-Energy
URG
$485M
$14K ﹤0.01%
17,050
+1,000
+6% +$727
OXBR icon
1845
Oxbridge Re Holdings
OXBR
$12.7M
$13K ﹤0.01%
12,260
ENSV
1846
DELISTED
Enservco Corp.
ENSV
$13K ﹤0.01%
1,667
SDPI
1847
DELISTED
Superior Drilling Products Inc.
SDPI
$13K ﹤0.01%
10,200
CARG icon
1848
CarGurus
CARG
$3.01B
$12K ﹤0.01%
+300
New +$11.7K
PTN
1849
Palatin Technologies
PTN
$13.7M
$12K ﹤0.01%
+10
New +$10.5K
TOPS icon
1850
TOP Ships
TOPS
$4.32M
0

Similar funds

Creative Planning's Q1 2019 Portfolio in Review

As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.

By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.

  • Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
  • Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
  • Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
  • Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
  • Creative Planning opened 217 new positions and closed 175 in Q1 2019.
  • Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.

Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.